AI assistant
CONMED Corp — Director's Dealing 2013
May 29, 2013
31971_dirs_2013-05-29_0cb7d9e3-cc49-4ed4-a730-56fbe8e60426.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-05-28
Reporting Person: Cohen Heather L (VP CORP HR&DEPUTY GEN COUNSEL)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-28 | Common Stock | M | 2000 | $26.69 | Acquired | 5687 | Direct |
| 2013-05-28 | Common Stock | F | 1726 | $34.04 | Disposed | 3961 | Direct |
| 2013-05-28 | Common Stock | M | 2000 | $19.26 | Acquired | 5961 | Direct |
| 2013-05-28 | Common Stock | F | 1447 | $34.04 | Disposed | 4514 | Direct |
| 2013-05-28 | Common Stock | S | 2522 | $34.463 | Disposed | 1992 | Direct |
| 2013-05-28 | Common Stock | S | 1165 | $34.616 | Disposed | 827 | Direct |
| 2013-05-29 | Common Stock | S | 827 | $33.4374 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-28 | Sars (Stock Appreciation Rights) | $26.69 | M | 2000 | Disposed | 2018-06-01 | Common Stock (2000) | Direct |
| 2013-05-28 | Sars (Stock Appreciation Rights) | $19.26 | M | 2000 | Disposed | 2020-06-01 | Common Stock (2000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.18 to $34.58. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.60 to $34.72. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.36 to $33.51. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
F4: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.
F5: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.